Enabling Drug Formulation with Hot-Melt Extrusion

Formulation scientists face mounting pressure to bring complex molecules to market with higher efficacy, stability, and patient compliance. As more APIs fall into BCS Class II or IV—poorly soluble, poorly permeable, or both—formulators are forced to innovate or fall behind.

Hot-melt extrusion (HME) has become a cornerstone of modern drug…